Laurie D. Stelzer
2020
In 2020, Laurie D. Stelzer earned a total compensation of $171.2K as Former Senior Vice President, Chief Financial Officer at Halozyme Therapeutics, a 92% decrease compared to previous year.
Compensation breakdown
| Salary | $93,225 |
|---|---|
| Other | $77,996 |
| Total | $171,221 |
Stelzer received $93.2K in salary, accounting for 54% of the total pay in 2020.
Stelzer also received $78K in other compensation.
Rankings
In 2020, Laurie D. Stelzer's compensation ranked 12,691st out of 13,090 executives tracked by ExecPay. In other words, Stelzer earned more than 3.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,691 out of 13,090 | 3rd |
Division Manufacturing | 5,442 out of 5,620 | 3rd |
Major group Chemicals And Allied Products | 2,197 out of 2,253 | 3rd |
Industry group Drugs | 1,909 out of 1,953 | 2nd |
Industry Biological Products, Except Diagnostic Substances | 405 out of 411 | 2nd |
Pay ratio
| Laurie D. Stelzer's Pay | $171,221 |
|---|---|
| Median Employee's Pay | $223,441 |
| Pay Ratio | 1to 1 |
In 2020, the annual total compensation of Laurie D. Stelzer was $171,221.
The annual total compensation of the median employee at Halozyme Therapeutics was $223,441.
The ratio of Laurie D. Stelzer's pay to the pay of median employee was therefore 1 to one.
Source: SEC filing on March 26, 2021.
Stelzer's colleagues
We found four more compensation records of executives who worked with Laurie D. Stelzer at Halozyme Therapeutics in 2020.